General Information of the Compound
| Compound ID |
CP0079810
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-(Dimethylamino)ethyl p-(butylamino)benzoate
Show/Hide
|
||||||||||||||||||
| Synonyms |
2-(Dimethylamino)ethyl 4-(butylamino)benzoate
2-(Dimethylamino)ethyl p-(butylamino)benzoate
2-Dimethylaminoethylester kyseliny p-butylaminobenzoove
2-Dimethylaminoethylester kyseliny p-butylaminobenzoove [Czech]
2-dimethylaminoethyl 4-(butylamino)benzoate
4-(Butylamino)benzoic acid 2-(dimethylamino)ethyl ester
4-[Butylamino]benzoic acid-2-[dimethylamino]ethyl ester
Amethocaine
Amethocaine (TN)
Anetain
BENZOIC ACID, p-(BUTYLAMINO)-, 2-(DIMETHYLAMINO)ETHYL ESTER
BENZOIC ACID,4-BUTYLAMINO,2-DIMETHYLAMINOETHYL ESTER PANTOCAIN BASE
Benzoic acid, 4-(butylamino)-, 2-(dimethylamino)ethyl ester
Contralgin
Diaethylaminoaethanol ester der p-butylaminobenzoesaeure;Diaethylaminoaethanol ester der p-butylaminobenzoesaeure [German]
Dicain
Dicaine
Dikain
Dimethylaminoethyl p-butyl-aminobenzoate
Fissucain
Intercain
Laudocaine
Medicaine
Medihaler-Tetracaine
Meethobalm
Metraspray
Mucaesthin
Niphanoid
P-(Butylamino)benzoic acid, 2-(dimethylamino)ethyl ester
P-Butylaminobenzoyl-2-dimethylaminoethanol
Pontocaine
Pontocaine (TN)
Rexocaine
Tetracaina
Tetracaina [INN-Spanish]
Tetracaine
Tetracaine (USP/INN)
Tetracaine [USAN:INN]
Tetracainum
Tetracainum [INN-Latin]
Tetrakain
Tetrakain [Czech]
Uromucaesthin
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C15H24N2O2
|
||||||||||||||||||
| Molecular Weight |
264.369
|
||||||||||||||||||
| Canonical SMILES |
CCCCNc1ccc(cc1)C(=O)OCCN(C)C
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C15H24N2O2/c1-4-5-10-16-14-8-6-13(7-9-14)15(18)19-12-11-17(2)3/h6-9,16H,4-5,10-12H2,1-3H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
GKCBAIGFKIBETG-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
94-24-6
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00918, Amine oxidase [flavin-containing] A
Protein ID: PT03022, Sodium channel protein type 2 subunit alpha
Protein ID: PT03042, Sodium channel protein type 3 subunit alpha
Protein ID: PT01105, Sodium channel protein type 5 subunit alpha
Protein ID: PT03581, Sodium channel protein type 8 subunit alpha
Protein ID: PT01000, Sodium channel protein type 9 subunit alpha
Cell-based Assay
Clinical Information about the Compound